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Equine hyperelastosis cutis (HC or HERDA), a connective tissue disorder in
American Quarter Horses, results in hyperelastic skin with poor wound healing. Similar
conditions are found in many species and all forms display decreased skin tensile
strength. Fibroblasts produce collagen and elastin fibers, forming networks, providing the
dermis with strength, and elasticity.
This study aims to carry out a 3-part evaluation between horse skin fibroblast
(cells from horses affected with HERDA, cells from horses that are carriers of HERDA
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1. Cell proliferation assay
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CHAPTER I
INTRODUCTION
Equine Hyperelastosis Cutis (HC)
Inherited connective tissue disorders have been identified and currently exist in
humans and a variety of domestic and laboratory animals; including cattle, cats, dogs,
sheep, and horses (Brounts 2001; Borges 2005). Ehlers-Danlos Syndrome (EDS), in
humans, is a clinically and genetically heterogeneous group of hereditable connective
tissue disorders characterized by hyper-extensibility of the skin, articular hypermobility,
and tissue fragility (Giunta 1999; Mao 2001; Whitelaw 2003; Borges 2005). EDS is
caused by abnormalities and defects in the collagen fiber structure resulting from
mutations in collagen genes, mutations in genes which encode enzymes that modify
collagens, and mutations in genes that encode other proteins that affect the nature of
extracellular matrix (Byers 1989). Clinical signs are instability and tearing of skin, easy
bruising, atrophic scars, prolonged bleeding mitral valve prolapsed, and chronic joint pain
(Brounts 2001; Mao 2001; Whitelaw 2003).
The classification of EDS is based on the extent and severity of the classic clinical
features and coexistent abnormalities, the most likely pattern of inheritance, and the
results of biochemical and molecular analyses. There are 6 major types of EDS which
includes the following: 1) Classical Type 2) Hypermobility Type 3) Vascular Type 4)
Kyphoscioliosis 5) Arthochalasia and 6) Dermatosparaxis (Whitelaw 2003); however,
there are more than 10 subtypes of EDS classified based on clinical genetic and
1

biochemical characteristics (Brounts 2001). The Classic Type (Type I and III) has an
autosomal dominant pattern of inheritance and is characterized by hyperextensibility of
the skin, tissue fragility, and hypermobility of the joints. Characteristics of hypermobility
type (Type III) are autosomal dominant pattern of inheritance, generalized hypermobility,
and hyperextensible skin (Giunta 1999). More specifically, biochemical studies of EDS
skin suggest hypermobility is most likely to reflect fibril disarray than extensibility of
collagen fibrils (Mao 2001).
The recognition of frequent ultrastructural abnormalities of collagen fibrils in
EDS patients led to the concept that EDS is a disorder of fibrillar collagen metabolism
(Mao 2001). The molecular defects described, to date, are not sufficient to explain the
disease in many EDS patients, including those with the most common classical and
hypermobility types (Mao 2001). The three known fundamental mechanisms of disease
producing EDS are the following: 1) Deficiency of collagen processing enzyme 2)
Dominant-negative effects of mutant collagen α-chains and 3) Haploin sufficiency.
Examples of deficient enzyme activity leading to EDS are lysl-hydroxylase deficiency,
and procollagen peptidase deficiency (Mao 2001). The concept that EDS is a disorder of
fibrillar collagen metabolism is well supported by identification of specific defects,
affecting collagen type I, III, and/or V, in the collagen biosynthetic pathway that produce
clinically distinct forms of EDS (Mao 2001; White 2004).
This study explores a very similar autosomal recessive disease most commonly
found in American Quarter horses called Equine Hyperelastosis Cutis (HC) or Hereditary
equine regional dermal asthenia (HERDA) (Brounts 2001; Carmalt 2004; White 2004;
Schott 2005; Tryon 2005; Tryon 2007; White 2007) . HC first surfaced in the 1970’s and
95% of the disease trace back to Poco Bueno as the sire line associated with origin. The
2

generative skin disease has also been reported in an Arabian mare, Thoroughbred
gelding, a Hanoverian foal, and Haflinger horse. Other findings are a single Arabiancrossbred horse and 6 Appaloosa or Paint Horses with Quarter Horse bloodline (Carmalt
2004; Schott 2005; Tryon 2005; Tryon 2007). The term Quarter Horse dates back to 17th
century used in short quarter-mile races in Colonial America (Tryon 2007). As settlers
migrated eastward across North America, the Quarter Horse became known for its
versatility, strength, and agility (Tryon 2007).
Horses affected with HC display a number of phenotypic symptoms shown below
in Figure 1; the characteristics related to the disease include the following:
1. Skin is loose and sloughing displayed in Figure 1A,
2. Skin is extensible and easy to pull away from the underlying fasciae
demonstrated in Figure 1B,
3. Affected skin is fragile, and may feel velvety to the touch,
4. Seromas and hematomas are most common lesions, along with open
wounds, abnormal skin, and scarring illustrated in Figure 1C,
5. Affected tissues are located predominately along the dorsum pointed out
in Figure 1D, although lesions can be found in other locations associated
with trauma,
6. Slow healing of the affected tissue when there is tearing or blistering
(Tryon 2005).
HC is a connective tissue disorder resulting in lesions most often found on the
dorsum, back, and withers, but are not limited to legs (Carmalt 2004; White 2004; Schott
2005; Tryon 2007). There are reports of lesions occurring early as 6 months of age
(Tryon 2005). Severe lesions may be single or multiple, and are reported most to develop
3

on average at 1.5 - 2 years of age (Brounts 2001; White 2004; Tryon 2005; Tryon 2007).
At this time, force, pressure, stress of saddling combined with rider’s weight leads to
severe wounds in horses affected with the disease. Due to these affects, HC horses are not
suitable for riding or breeding, and are usually euthanized after diagnosis (Brounts 2001;
Carmalt 2004; White 2004; Tryon 2007). Other characteristics also include slow-healing
wounds produced by minor trauma, poor adhesion in the dermis of the skin, and hair loss
or slight lightening of the hair coat over the lesion (Brounts 2001; Carmalt 2004; Borges
2005; White 2007).

Figure 1

HERDA-affected horses phenotypical characteristics. (A) A 2-year-old
stallion with mild dorsal lesions also having loose skin (white circle) (B)
Extensible skin of affected horse (C) A 1.5 year old affected horse with a
large hematoma developed on left side of dorsal (D) Additional ulcerations
and degeneration of the skin from right side of dorsal of horse shown in C.
(Images adapted from HERDA Mapping)
4

Characterization of the disease has led researchers to suggesting several names for
the disorder within the Quarter Horse family; “Hyperelastosis cutis” is meant to
demonstrate loose, easily torn skin of the affected condition, and excessive deposits of
elastic fibers (White 2004). More specifically, “elastosis” is defined as degeneration of
elastic tissue or fibers (White 2004). And “zonal dermal separation” refers to separation
between the deep and superficial dermis (Brounts 2001; Schott 2005).
Abnormalities of elastic tissue have not been detected on histopathologic
examinations of skin samples collected from affected horses; rather, subtle abnormalities
of collagen are found in the deep dermis (White 2004; Schott 2005). Noting histological
examinations do not ultimately diagnose the disease, but gives rise to pertinent
information concerning the internal cellular structure and functions of each component.
Histology has shown thinning, fragmentation, and disorientation of the collagen fibrils in
the mid to deep dermis (Brounts 2001; White 2004; Tryon 2007; White 2007). For
example, researchers studied the histology on the disorganization of collagen seen in
affected tissue (White 2004; Schott 2005; Tryon 2007). The unaffected tissue was taken
from affected horses, and samples appeared healthy and consistent with the control
samples. Although the phenotype of loose skin in affected areas is consistent with EDS,
the normal quality of skin in unaffected areas of the body and the disease’s progressive
nature suggest a distinct genetic cause (Tryon 2007). This group concluded that the
natural growth and development of skin of an affected horse may not be deficient with
regard to collagen metabolism (Tryon 2007). Leaving questionable whether or not the
protein product of the gene responsible for HERDA directly interacts with collagen or
more largely has an effect on post-trauma collagen deposition (wound-healing process).
For these reasons, a thorough investigation of HC carrier and affected cells is warranted.
5

Cellular Histology and Morphology
Mutations in collagen I, III, and IV; as well as, lysyl-hydroxylase and tenascin-x
have been identified in humans with EDS; specifically, tenascins are extracellular matrix
proteins highly expressed in connective tissue (Brounts 2001; Mao 2001; White 2004).
Understanding cellular histology and cellular morphology of HC/HERDA has given rise
to identifying the gene responsible for the disease.
Cells are known as the building blocks of life because they are the structural and
functional unit of all living organisms. The cell is the smallest unit of any classified living
organism (Alberts 2008). Eukaryotic and prokaryotic cells are the two types of cells;
prokaryotic cells are organisms that lack a nuclear membrane and do not develop or
differentiate into multi-cellular form. These two types of cells can be distinguished based
on nuclear organization. Eukaryotic cells contain membrane-bound compartments that
control metabolic activity (Alberts 2008). The nucleus of a cell houses the
deoxyribonucleic acid (DNA) the hereditary material of genes. The cell’s RNA contains
information necessary to make proteins. The nucleus is spherical in shape and is
separated from the cytoplasm by a membrane called nuclear envelope (Alberts 2008).
The cytoplasm makes up the cell’s inner space, contains many salts, and creates the
perfect environment for the mechanics of the cell. Cytoskeleton organizes and maintains
the cell’s shape by keeping the organelles in place. Organelles of the cells include:
nucleus, mitochondria, chloroplast, endoplasmic reticulum, Golgi apparatus, ribosome,
lysosome, centrosomes, and vacuoles. The mitochondria plays a vital role in generating
energy in the eukaryotic cell; the outer membrane of the mitochondria surrounds the
organelle (Alberts 2008). The chloroplast of eukaryotic cells contains its own genome
that is separate and distinct from the nuclear genome of a cell. The endoplasmic
6

reticulum (ER) is the transport network for molecules targeted for certain modifications
and specific destinations. There are two forms of ER: 1) Rough ER has ribosomes
adhering to its outer surface, and 2) Smooth ER serves as the recipient for those proteins
synthesized in the rough ER (Alberts 2008). Proteins to be exported are passed to the
Golgi apparatus which is also known as Golgi body. Large complexes composed of many
molecules, ribosomes, are floating freely in the cytoplasm. They are responsible for
processing the genetic instruction carried by mRNA (Alberts 2008). All of these cellular
components are located inside an outer lining called the plasma membrane. Serving as the
cell’s protective coat, this membrane is made of a double layer of proteins and lipids and
it pumps other molecules into and out of the cell (Alberts 2008). The structure and
function of a cell tells the overall story of the many unknown diseases because it’s simply
the origin of all life.
Generally, connective tissue cells contribute to the support and repair of almost
every tissue and organ. These cells are jointly responsible for the architectural framework
of the body. Hyperelastosis cutis is the most prevalent heritable disorder of connective
tissue in horses. Mutations in collagen genes, genes that encode enzymes that regulate
collagen, and mutations in the genes that encode proteins that affect the nature of the
extracellular matrix cause the development of this connective tissue disorder (Alberts
2008). So, it is critical to understand the physiology and hierarchy of skin as an organ.
Skin is the outermost tissue of the body and it acts a barrier to the external
environment protecting from friction and impact wounds with its flexibility and
toughness (Alberts 2008). Skin has a very complex structure consisting of many
components. Cells, fibers, and other molecules make up the multi-layered structure of
skin including the following primary layers: 1) Epidermis 2) Dermis and 3) Subcutaneous
7

(Alberts 2008). The epidermis is the outermost and very thin layer of skin consisting of
cells; this layer of tissue is metabolically active. The second layer of skin beneath the
epidermis is called the dermis; this layer is a thick layer composed of mainly fibers
(Alberts 2008). Because skin diseases are usually caused by disorders in the micro-scale
components, our focus is on the structure and constituents of these layers (Alberts 2008).
The cells included in the skin are keratinocytes, fibroblast, fat cells, melanocytes, and
erythrocytes; each has different locations, structures, and functions. The focus of this
study is specifically on fibroblast from HC horses.
Fibroblasts have high importance in the overall health of skin; they are long and
narrow cells in shape that are present in the dermis (Tinker 1985; Wang 2006). Producing
collagen and elastin fibers, which are the major building blocks of the skin, fibroblast
aids in its structural integrity. Elastin is a structural protein found in the skin. These fibers
are random coiled proteins providing the skin with elasticity and resilience. Research has
shown elastin to compose 70-90% of elastic fibers (Tinker 1985; Wang 2006). Whereas,
collagen forms vast and tough networks providing the dermis of the skin with strength,
tension, and elasticity; the hierarchical structure is made up of small bundles called
collagen fibrils, a triple helix polypeptide chain (Tinker 1985; Wang 2006). Figure 2
demonstrates the make-up of collagen fibrils (67 nm x 10-300 nm) beginning with the
polypeptide chain (~300 nm x 1.5 nm) that form the triple-stranded collagen molecule. It
is essential to note, collagen is the most abundant animal protein (~ 30% of the total
proteins in mammals) and is also responsible for the tensile property of tissue (Tinker
1985).

8

Figure 2

Hierarchy of collagen fibril. The make-up of the triple-helix collagen fibril
beginning with the polypeptide chain which together forms the triplestranded collagen molecule and compose the collagen fibril. (Adapted from
http://course1.winona.edu/sberg/ILLUST/fig11-3.gif)

It is apparent fibroblast and a number of matrix proteins greatly contribute to the
structural; as well as, the mechanical properties of connective tissue. Therefore,
additional information on fibroblast proliferation, mechanics, and microstructure may
inform us if the cells are compromised in any manner, which may ultimately alter the
cell’s collagen and elastin production and have a large effect on the mechanical
properties of the skin.
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CHAPTER II
REVIEW OF LITERATURE
Fibroblasts synthesize, organize, and maintain connective tissue during
development and in response to injury and fibrotic disease. Carrying out these activities
depends on the ability of the cell to exert mechanical force and to remodel the
extracellular matrix (ECM) (Fibroblast biology in 3-D). Biochemical measurements and
microarray analysis of gene expression show that mechanical loading leads to a synthetic
cellular phenotype characterized by increased matrix synthesis and decreased matrix
degradation. In addition, fibroblasts in matrices under tension or relaxed respond
differently to growth factor stimulation and switching between mechanically loaded and
unloaded conditions influence whether cells acquire proliferative biosynthetic active or
quiescent resting phenotype (apoptosis) (Fibroblast biology in 3-D). The cell responses to
the describe processes are investigated.
Mechanobiology of the Cell
Alterations in the composition, structure, and function of living tissue primarily
result from external mechanical forces. Mechanobiology is the interdisciplinary study
relating the cell responses to mechanical forces (Wang 2006). Physiological or
pathological effects in the ECM are caused because of the cells’ response to mechanical
forces on the tissue. The ECM is very important in this study because it is made up of
proteins including collagen, elastin and glycoprotein; in addition to, proteoglycans that
provides strength and attachment sites for cell surface receptors (Wang 2006). The ECM
10

also regulates cell proliferation, migration, and differentiation (Wang 2006). Many
studies have shown mechanical forces affect the gene induction, protein synthesis, cells
growth, and cell death. For example, human tendon fibroblasts were subjected to uniaxial
stretching, with constant frequency and duration (0.5Hz, 4hr), but varying magnitudes of
stretching (4% and 8%), and cell proliferation collagen type-I gene expression and
protein production all increased in a stretch-magnitude dependent manner (Wang 2006).
Similarly, other researchers subjected tendon fibroblast to cyclic biaxial stretch and
concluded the increase in cell proliferation depended on the stretching time (Zeichen
2000). It was also pointed out that prolonged mechanical stretching can have inhibitory
effects on cells. For instance, another study in human tendon fibroblasts reports when a
5% repetitive stretching magnitude at 1 hertz (Hz) was applied for 1 day, cell
proliferation was significantly increased; however, when the same conditions were
applied for 2 days, cell proliferation was inhibited (Wang 2006).
Mechanical forces also induce a variety of cellular responses including
morphological changes, protein synthesis, and gene expression (Wang 2001). For
example, almost every type of cells, when subjected to cyclic stretching, align nearly
perpendicular to the primary stretching directions and the actin cytoskeletons of these
stretched cell were found to be remodeled into bundles of actin filaments oriented near
the perpendicular direction. It was concluded that the cell orientation appeared to be
depended on the stretching magnitude – the larger the stretch, the farther the cells
oriented away from the stretching direction (Wang 2001). However, it was unclear if the
change in cell alignment was due to actual cell reorientation or selective detachment of
cells in certain directions. Wang et.al. continued investigation of these theories by
subjecting human aortic endothelial cells to three types of cyclic stretching: simple
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elongation, pure uniaxial stretching, and equi-biaxial stretching. They concluded after 3
hours of stretching, the cells subjected to 10% stretch had nearly completed their
reorientation, but those subjected to 5% had not. It was also noted that with increased
passages, the cells tend to lose some phenotypic properties (Wang 2001)
Biochemical effects of the cell
Fibroblasts have specialized responses to biochemical effects; whether HC cells
undergo cell quiescence (apoptosis) or cell proliferation is unknown prior to this study.
Apoptosis, or programmed cell death (PCD), is a normal physiological process that
occurs during embryonic development; as well as, in the maintenance of tissue
homeostasis. This process is initiated in response to various stresses such as irradiation or
irreparable DNA damage. It could also involve a series of biochemical events leading to a
characteristic cell morphology and death. Possibly, it could also resulting a series of
biochemical events that lead to morphological changes, including blebbing, changes to
the cell membrane, such as, loss of membrane asymmetry and attachment, cell shrinkage,
nuclear fragmentation, chromatin condensation, and chromosomal DNA fragmentation
which distinguishes apoptosis from necrosis or accidental cell death. Organellar structure
is usually preserved intact, but the nucleus undergoes a characteristic condensation of
chromatin. This process is responsible for cell death in development, normal tissue
turnover, atrophy induced by endocrine and other stimuli, negative selection in the
immune system, and a substantial proportion of T-cell killing. It also accounts for many
cell deaths following exposure to cytotoxic compounds, hypoxia, or viral infection.
In contrast, the health of cells is usually noted by the term cell proliferation or
viability; it is the measurement of the number of cells that are dividing in a culture. Cells
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do not undergo division unless they receive signals that instruct them to enter the active
segments of the cell cycle shown below in Figure 3. Resting cells are said to be in the Go
phase (quiescence) of the cell cycle. The signals that induce cells to divide are diverse
and trigger a large number of signal transduction cascades. These signals are called
growth factors, cytokines, or mitogens. Mammalian fibroblasts require mitogens to
progress through the G1 phase of the cell cycle. When cells have passed the checkpoint
late in G1 they enter the S phase and complete the cell cycle without further stimulation
by mitogens (Iyer 1999; Kues 2000).

Figure 3

The Cell Cycle. The sequence of events and activities in which cells
exhibit. (Adapted from http://herb4cancer.files.wordpress.com/2007/
11/cell-cycle2.jpg).

Studies have shown adding serum or growth factors to fibroblasts have
proliferative effects on the fibroblast; in addition, serum deprivation is a commonly used
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method to synchronize cell lines in the G0 phase of the cell cycle (Iyer 1999; Kues 2000).
Subjecting HC affected cells to both methodologies provides information on HC cells
responses to these biochemical effects.
Mechanobiolgy and Biochemical effects on HC cells
This review provides direction for a thorough study on the mechanobiology and
biochemical effects on HC cells. Because HC is a connective tissue disorder that results
in poor wound healing with many unknowns concerning the cellular level of the disease,
this widely opens the door that there may be defects within the ECM and its protein
production. Fibroblasts are versatile, connective tissue cells. For example, fibroblasts
from different parts of the body are intrinsically different, and they may produce
differences in a single region. Fibroblasts from the dermal layer of the skin change their
functions; case in point, at a healing wound, they change their actin gene expression and
take on some of the contractile properties of smooth muscle cells. Helping to pull the
wound margins together, these cells function by assisting in ECM repair. From this, it can
be extracted that the ECM contains components that influence the differentiation of
connective-tissue cells. For example, cells attach to the ECM by way of integrins that are
connected to the cytoskeleton allowing the transmission of a mechanical signal. In
contrast, if the cells do not attach to the ECM, they will not detect and transmit
mechanical signals well and this could in turn effect gene expression. As previously
discussed, biochemical effects and mechanical forces alter many of the cell functions.
Because the ECM influences the differentiated state of connective tissue cells through
physical and chemical effects, the relationship of stress, weight, and pressure of external
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forces on HC horses is warranted. This study reports cell proliferation analysis, and two
methods of apoptosis-induced experiments of HC cells which include serum starvation.
Rationale
Hyperelastosis cutis is recognized to be more common in Quarter horses used for
the cutting sport. An official registry of American Quarter Horses was started in 1941; as
of today, it is the largest breed in the world, registering 165,057 new horses in 2005.
Between 1998-2002, twelve thousand forty-one off-springs from sires were sold at an
auction and it is believed one-half of these horses are likely carriers of HERDA gene
(Schott 2005). Pedigree analysis of affected horses has demonstrated consanguinity in
both sires and dams’ lineage to a prominent Q.H. Stallion. Unfortunately, many offsprings of this stallion have been successful cutting horses resulting in 14 of today’s top
cutting stallions are suspected carriers of the disorder. HC affects males and females
equally. For owners and breeders, a considerable amount of time, effort, and money has
been invested in an affected horse by the time the disease is diagnosed. The National
Cutting Horse Association approved events offering total purchases exceeding $39
million as of 2006. Although the disease is not life-threatening, it is important to note,
breeding affected horses will transmit the disease allele to the next generation and
affected horses are often subjected to humane euthanasia because of the reoccurrences of
skin lesions (Schott 2005; Tryon 2005).
As described previously, the similitude between EDS and HC is skin
hyperextensibility, tissue fragility, and joint hypermobility (Whitelaw 2003). Research
has shown that EDS is caused by abnormalities or defects in the collagen fiber structure
and all forms of the disease display decreased tensile strength in the skin (Whitelaw
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2003). The recognition of frequent ultrastructural abnormalities of collagen fibrils in EDS
patients led to the concept that EDS is a disorder of fibrillar collagen metabolism (Mao
2001; Whitelaw 2003).
The Ehlers Danlos Syndrome gene is dominant meaning only a single gene with
the mutation is needed to express effects. For example, if one parent is affected with
EDS, and the other parent is normal, they have a 50% risk of having an affected child and
a 50% chance of having a normal child (Whitelaw 2003). EDS affects as many as 1 in
5,000 individuals per year, and is also known to affect both males and females of all
racial and ethnic backgrounds (Mao 2001; Whitelaw 2003).
With hopes of embracing a possible treatment for both HC/HERDA and human
EDS, the completion of this study will be a valuable asset in understanding the defects of
these disorders on a molecular level.
Objectives
This thesis aims to carry out micromechanical analysis between horse skin
fibroblast (cells from horses affected with HERDA, cells from horses that are carriers of
HERDA (recessive HERDA gene), and cells from horses that are normal (neither
affected or carriers of HERDA); cell proliferation assay, which measure the number of
fibroblasts dividing in a culture and DNA synthesis giving accurate cell proliferation
data, apoptosis of fibroblasts, and mechanobiology of stretched fibroblast are foci.
Fetal bovine serum (FBS) or purified growth factors induces proliferation of
fibroblasts; Cell proliferation is a measurement of the number of cells dividing in a
sample. Bromodeoxyuridine (5-bromo2’-deoxy-uridine or BrdU) assay will allow the
quantification of DNA synthesis or cell proliferation in each condition of this study. This
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will be done by incorporating 5-bromo2’-deoxy-uridine into the cellular DNA. Cells,
which have incorporated BrdU into DNA, can be quickly detected using a monoclonal
antibody against BrdU and an enzyme- or fluorochrome-conjugated secondary antibody.
The binding of the antibody is achieved by denaturation of the DNA. This is usually
obtained by exposing the cells to acid, base or heat. Projected to provide results for
conclusive comparison of proliferation rates between each condition, BrdU is expected to
give insight on the wound healing process and provide an overall understanding of any
differences of alterations in cell growth between the three conditions.
Apoptosis is a normal component of the development and health of multi-cellular
organisms. Cells die in response to a variety of stimuli. During apoptosis, they do so in a
controlled, regulated fashion-making apoptosis distinct from other forms of cell death.
For example, in necrosis, uncontrolled cell death leads to lysis of cells, inflammatory
responses and, potentially, to serious health problems. Apoptosis, by contrast, is a process
in which cells play an active role in their own death (which is why apoptosis is often
referred to as cell suicide). Apoptosis will be induced by two methods: serum starvation
and mechanical stretching.
Fibroblasts require growth factors for proliferation in culture; these growth factors
are usually provided by FBS. Typically, in the absence of growth factors, fibroblasts
enter a non-dividing state, G0, characterized by low metabolic activity.
Mechanical forces induce a variety of cellular responses including morphological
changes, protein synthesis, and gene expression (Wang 2001). It has also been shown that
cyclic stretching of cells induces various biological responses including remodeling of
actin cytoskeleton and changes in cell proliferation. Because apoptotic cells display
distinctive morphology during the apoptosis process, applying mechanical loads to each
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condition is anticipated to demonstrate the response to mechanobiology,
mechanotransduction, and biochemical effects. Thus, in this study, we will stretch
fibroblasts and analyze results using flow cytometry to obtain a better understanding of
HC carriers and affected horses.
Specific Aims
1. To analyze and quantify cellular proliferation of HC normal, carrier and
affected fibroblast.
2. To characterize the effects of induced apoptosis of HC normal, carrier and
affected fibroblast (via serum starvation and mechanical stretching).
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CHAPTER III
MATERIALS AND METHODS
To increase the knowledge of HC on the cellular level, a preliminary thorough
analysis of horse skin fibroblast structure was investigated via electron microscopy
(SEM, TEM and confocal light microscopy), cell proliferation assay (BrdU), and
apoptosis (serum starvation and cellular mechanics).
Three conditions of the fibroblasts were evaluated: 1) cells from horses affected
with HERDA, 2) cells from horses that are carriers of HERDA (recessive HERDA gene),
and 3) cells from horses that are normal (neither affected or carriers of HERDA). Horses
available for this study included two affected with HERDA, two carriers of HERDA, and
two normal horses (used as controls). All horses were age, passage, and sex matched for
this investigation. Skin samples were taken from each horse to culture fibroblasts
(discussed later in this chapter). The tissue collection process is demonstrated in Figure 4.

Figure 4

Tissue collection and culture process shows the initial steps of obtaining
samples and culturing, and process of naming passages.
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To ensure proper testing procedures for comparison purposes, the schematics
below display the systematic approach used in this study. Normal or Unaffected
condition (denoted by green), shown in Table 1, demonstrates two horse of this condition
will be used in Applications 1-4. The table shows 2nd or 3rd cell passages were used in the
study, and describes percentage of confluence used for each application.
Represented in Table 2 is the schematic of Carrier Condition Testing Procedures.
It also illustrates that 2nd and 3rd cell passages were used in carrier conditions (denoted by
color blue). The same applications and parameters are used for testing procedures of
affected conditions (denoted by color red) shown below in Table 3.
For all conditions and applications, a control is used. For example, the control
samples used for cell proliferation assays were passage 2 cells at 100% confluence. And
control samples used for both apoptosis experiments were passage 3 at a confluence level
between 70-80%.
It is also important to note each condition and application had varying times of
cellular growth prior to testing. Detailed time periods will be discussed in each specific
section of testing.
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Table 1

Schematic of Normal (Unaffected) Condition Testing Procedures

Unaffected
condition
(N/N)
Horse 1

Application (#) Application
1
2

Control
Cell proliferation:
BrdU assay
Apoptosis:
Serum starvation
Apoptosis:
Mechanical
stretching
Control
Cell proliferation:
BrdU assay
Apoptosis:
Serum starvation
Apoptosis:
Mechanical
stretching

3
4
Horse 2

1
2
3
4

Table 2

2

100%

3

70-80%

3

70-80%

3

100%

2

100%

3

70-80%

3

70-80%

Schematic of HC/HERDA Carrier Condition Testing Procedures.

Carrier
Condition
(N/Hr)
Horse 1

Application
(#)
1
2
3
4

Horse 2

Cell Passage (#) Confluence
(%)
2 or 3
100%

1
2
3
4

Application
Control
Cell proliferation:
BrdU assay
Apoptosis:
Serum starvation
Apoptosis:
Mechanical
stretching
Control
Cell proliferation:
BrdU assay
Apoptosis:
Serum starvation
Apoptosis:
Mechanical
stretching
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Cell Passage
(#)
2 or 3

Confluence
(%)
100%

2

100%

3

70-80%

3

70-80%

3

100%

3

100%

3

70-80%

3

70-80%

Table 3
Affected
Condition
(Hr/Hr)
Horse 1

Schematic of HC/HERDA Affected Condition Testing Procedures.
Application
(#)
1
2
3
4

Horse 2

1
2
3
4

Application
Control
Cell proliferation:
BrdU assay
Apoptosis:
Serum starvation
Apoptosis:
Mechanical
stretching
Control
Cell proliferation:
BrdU assay
Apoptosis:
Serum starvation
Apoptosis:
Mechanical
stretching

Cell Passage Confluence
(#)
(%)
2 or 3
100%
2

100%

3

70-80%

3

70-80%

3

100%

3

100%

3

70-80%

3

70-80%

Specimen Preparation
Collection of tissue included taking sterile punch biopsies from withers area of
each horse and placing in sterile phosphate buffer saline (PBS) for transporting purposes.
Culturing surfaces were coated with fibronectin costing mix (FNC) (AthenaES,
Baltimore, MD), and incubated for at least 1 hour prior to adding minced pieces of tissue
(sterile) to “start-up” media. Cells were incubated at 37°C, at least 70% humidity, 5%
CO2 (normal culture conditions), and monitored daily; minced tissue pieces were
removed after cells were apparently adhered to surface. “Start-up” media was changed
every 48 hours, and used until cells were out of T25 size flask. After transferring out of
T25 flask, “complete” media was changed every 48 hours. All solutions were brought to
37°C in a water bath before contacting cells.
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Start-up Media Recipe
Media used is Dulbecco’s Modified Eagles Medium (DMEM) (Sigma Aldrich, St.
Louis, MO). “Start-up” media includes 20% Fetal Bovine Serum (FBS), 1mL Penicillin/
Streptomycin (Pen/Strep) (Sigma Aldrich, St. Louis, MO) per 100 mL of media (0.01
mL/mL), 100 µL of Fungizone (FZ) / 500 mL of media (0.2 µL/mL), and 500µL of
epidermal growth factor (EGF) / 500 mL of media.
Complete Media Recipe
Media used is Dulbecco’s Modified Eagles Medium (DMEM) (Sigma Aldrich, St.
Louis, MO). “Complete” media is made up of 10% FBS, and 1 mL of Pen/Strep per 100
mL of media (0.01 mL/mL).
Serum Free Media
Media used is Dulbecco’s Modified Eagles Medium (DMEM) (Sigma Aldrich, St.
Louis, MO) with 1 mL of Pen/Strep per 100 mL of media (0.01 mL/mL).
Specimen Preparation: Electron Microscopy
All horse skin fibroblasts samples are grown in an incubator to 70-80%
confluence on Thermanox coverslips. Specimens are fixed in modified Karnovsky’s
fixative (1.25 % glutaraldehyde + 2% formaldehyde) made in 0.1 M sodium cacodylate
buffer (pH 7.2). Coverslips are rinsed in buffer and post fixed in 2% buffered (0.1 M
sodium cacodylate) osmium tetraoxide. After dehydration through a graded ethanol
series, the cover slips are divided in half to be processed for Scanning Electron
Microscopy (SEM) and Transmission Electron Microscopy (TEM) analysis.
Continued preparation for SEM includes coverslips being chemically dried using
hexamethyldisilazane (HMDS) and air dried overnight. Samples were then mounted on
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aluminum stubs, coated with gold/palladium, and viewed using JOEL JSM-6500F
Scanning Electron Microscope at 5kV.
Coverslips were infiltrated and embedded in Spurr’s resin. Ultra thin sections
(~60-80 nm) were cut with a Reichert –Jung Ultracut E ultramicrotome and stained with
alcohol uranyl acetate followed by Reynold’s lead citrate. Stained sections were viewed
using JOEL JEM-100CXII transmission electron microscope at 80kV.
Fibroblasts were grown (70% confluence) on glass cover slips, fixed with 1.25 %
glutaraldehyde and 2% formaldehyde, washed twice with PBS, and stained with DAPI
with Vectashield (VECTOR Laboratories, Burlingame, CA) for confocal light
microscopy imaging. Stains were viewed using Zeiss LSM 510.
Specimen Preparation: Cell proliferation
Cellular proliferation was measured using a BrdU Labeling and Detection Kit
(Roche, San Francisco, CA). Fibroblasts (70-80% confluent) were split by trypsinizing
and plated in tissue cultured treated 96-well assay-plates Black plate, clear bottom with
lid (Corning Corporation, Corning, NY) (also coated with FNC). Cells were cultured in
100µL “complete media” under normal culturing conditions (37°C, 70% humidity, 5%
CO2 incubator) for 48 hours.
BrdU (10 µL) was added to cells at the end of the lag phase; this is recognized
when cells began to protrude out of the cluster of cells. Cells were then placed back into
the incubator until desired testing time (Analyzed at 4, 12, and 18 hours). Continued
preparation included washing cells twice in 250µL of medium with 10% serum, adding
200µL of pre-cooled fixative for 30 minutes at -15 to -25ºC, discarding fixative, washing
3 times with 250µL of medium with 10% serum, adding 100µL of nucleases, incubating
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at 37º for 30 minutes, discarding nucleases, washing 3 times with 250µL of medium with
10% serum, adding 100µL of anti-BrdU-POD incubating at 37ºC for 30 minutes,
discarding conjugate, washing 3 times with 250µL of washing buffer, and adding 100µL
of POD substrate at 15-25ºC for 2-30 minutes. BrdU incorporated into newly synthesized
DNA of replicating cells was quantified using Molecular Devices Spectramax Gemini XS
(405nm with reference wavelength at ~ 490nm).
Specimen Preparation: Apoptosis – Serum Starvation
Fibroblasts of each condition were cultured in sterile, treated 6-well plates under
normal culture conditions in complete media for ~ 7 days to 70-80% confluence. Cells
were serum deprived using serum-free media for 24 hours. Apoptosis analyses were
completed using flow cytometry; cells were prepared by adding 1mL of trypsin and
centrifuged in 5X (more than trypsin) media with FBS. The mixture was centrifuged at
1500 rpm for 10 minutes. Single suspension with a density of 105-107 is required for
accurate measurements; therefore, the supernatant was discarded, cells were re-suspended
in FACS-PBS (PBS supplemented with 2.5% FCS and 0.01% NaN3), and stained with
Hoechst 33342 and propidium iodide (PI) using Vybrant Apoptosis Assay Kit # 5
(Invitrogen Corporation, Carlsbad, CA), and measurements were taken using flow
cytometer (BD FACS Caliber).
Specimen Preparation: Apoptosis – Mechanical stretching
Fibroblasts of each condition were grown on collagen type I on BioFlex Culture
Plates shown below in Figure 5 (Flexcell International, Hillsborough, NC). Surfaces were
also coated with FNC. Fibroblasts were cultured for ~ 7 days to 70-80% confluence and
flexed using FX-4000TFlexercell Tension Plus (Flexcell International, Hillsborough, NC)
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under normal culture conditions with complete media. Other parameters included the
following: base-plate set-up consisting of EFIx Loading Station (25mm), and vacuum
pressure pump to deform a flexible-bottomed culture plate yielding 20% strain rate for a
period of 10 hours. Figure 6A demonstrates the equi-biaxial stretch subject to fibroblast
being pulled in every x-y position creating an evenly distributed force about the cells. For
the equi-biaxial stretching, the membrane is stretched equally in both the horizontal and
vertical directions, and therefore the axial strain is constant from 0° to 90° illustrated in
Figure 6B. Axial strain represents the substrate strain at a specific angle (θ) with respect
to the stretching direction (WANG, 2001).

Figure 5

Bioflex Culture Plate from Flexcell International Corporation. Six (6)-well
plates has a total growth surface area of 57.75 cm2 and covalently bound
matrix surface f Collage Type I. (Adapted from Flexcell International
Corporation)
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A
Figure 6

B

Schematic of Equibiaxial Stretch. A. The dotted lines represent a central
region on the membrane before stretching, and the solid lines represent the
same region after stretching. B. The axial strain for equi-biaxial stretching
is constant. (Adapted from Wang, 2001)

After stretching, cells were prepared for analysis; media was removed and
discarded. Cells were pulled up by adding 1mL of trypsin and placing in the incubator
for 2 minutes. Once cells appeared to be released, media with FBS (5 times the amount of
trypsin) was added and solution was centrifuged at 1500 rpm for 10 minutes. Because
flow cytometry analysis requires single suspension with a density of 105-107, supernatant
was discarded, cells were re-suspended in FACS-PBS (PBS supplemented with 2.5%
FCS and 0.01% NaN3), and stained with Hoechst 33342 and propidium iodide (PI) using
Vybrant Apoptosis Assay Kit # 5 (Invitrogen Corporation, Carlsbad, CA), and
measurements were taken using BD FACSCaliber flow cytometer.
Fundamentals of Flow Cytometry
In flow cytometry, the nuclei (component of the cell containing DNA) are stained
with fluorescent dye as discussed in previous section. After the dye binds to the DNA, the
solution is placed in the flow cytometer. One of the fundamentals of flow cytometry is
the ability to measure the properties of individual particles. Samples in solution are
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injected into a flow cytometer, and the particles are randomly distributed in threedimensional space. The sample passes through a process managed by the fluidics system
in which cells are ordered into a stream of single particles that can be interrogated by the
machine’s detection system. Essentially, the fluidics system consists of a central
channel/core through which the sample is injected, enclosed by an outer sheath that
contains faster flowing fluid (see Figure 7A). The effect creates a single file of particles
and is called hydrodynamic focusing. The flow characteristics of the central fluid can be
estimated using Reynolds Number (Re):

where D = tube diameter, V = mean velocity of fluid, p = density of fluid, and µ=
viscosity of fluid.
After hydrodynamic focusing, each cell passes through one or more beams of
light. Light scattering or fluorescence emission (if the particle is labeled with a
fluorochrome) provides information about the particle’s properties. For instance, the
fluorescent dye is bound to the DNA in the nucleus of the cell, and the intensity or
brightness of the cell’s fluorescence is proportional to the amount of the DNA in the cell.
Light that is scattered in the forward direction, typically up to 20º offset from the laser
beam’s axis, is collected by a lens known as the forward scatter channel (FSC). The FSC
intensity roughly equates to the particle’s size and can also be used to distinguish
between cellular debris and living cells. Light measured approximately at a 90º angle to
the excitation line is called side scatter. The side scatter channel (SSC) provides
information about the granular content within a particle.
The specificity of detection is controlled by optical filters, which block certain
wavelengths while transmitting others. The three major filter types include the following:
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1. Long pass filters - allow light through above a cut-off wavelength
2. Short pass - permit light below a cut-off wavelength
3. Band pass - transmit light within a specified narrow range of wavelengths
When a filter is placed at a 45º angle to the oncoming light it becomes a dichroic
filter/mirror. All these filters block light by absorption shown in Figure 7B.

Figure 7

Fundamentals of Flow Cytometry. A. Hydrodynamic focusing produces a
single stream of particles B. Multiple types of optical filters C. Electrostatic
flow sorting D. Schematic overview of typical flow cytometer setup.
(Images adapted from http://www.abdserotec.com/uploads/FlowCytometry.pdf)

The cell droplets eventually pass through a strong electrostatic field, and are
deflected left or right based on their charge (see Figure 7C). The data in each parameter is
known as the “events” and refer to the number of cells displaying the physical features or
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markers of interest. An overview of the flow cytometry process with detection of
multiples is illustrated in Figure 7D.
Results are displayed in a single measurement parameter (relative fluorescence or
light scatter intensity) on the x-axis and the number of events (cell count) on the y-axis in
a histogram. The histogram is useful for evaluating the total number of cells in a sample
that possess the physical properties selected for or which express the marker of interest.
Cells with the desired characteristics are known as the positive (control) dataset. Ideally,
flow cytometry will produce a single distinct peak that can be interpreted as the positive
dataset. In order to identify the positive dataset, flow cytometry was repeated in the
presence of an appropriate negative control.
Statistics
Statistical analysis was performed using a One-Sample T-test, and analyzed using
SPSS Statistics 17.0.0 (August 23, 2008).
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CHAPTER IV
RESULTS
Electron Microscopy
Results obtained from electron microscopy permitted visual and quantitative
analysis of horse skin fibroblast via SEM, TEM and Confocal Light Microcopy. The
micrographs and quantified results of cellular components from each condition are
presented in this section.
Scanning Electron Microscopy
SEM micrographs provide a better understanding of surface appearance including
growth patterns and cell shapes between the normal, carrier and affected conditions
included in this study. Figure 8A shows the SEM image of fibroblast cells from the
normal (control) condition at the magnification of 90X. Cells have completely migrated
over the coverslip in a uniformed manner. The SEM image (Figure 8B) of cells from
carrier condition, also taken at 90X magnification, displays a less uniformed and
structured growth pattern. As the carrier cells begin growth and migrate, the cells are
visually more comparable to cells of the affected condition, but as confluence increase,
the cells take on the uniform growth pattern of normal cell. Figure 8C is a SEM
micrograph of the affected condition taken at 90X magnification. These cells have a
unique proliferating mechanism; affected cells have a non-uniform and non-structured
growth pattern, but they proliferate at a much higher rate than the other two conditions.
This is presented later in the chapter. It is important to note that the images of this study
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were taken at different stages in culture time due to confluence levels between each
condition. There were no significant SEM analyses of cell shape between each condition
to give rise to the aims of this study; however, another methodology used to analyze size
and shape of cells from each condition will be also discussed later in this section.
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A

B

C
Figure 8

Scanning Electron Microscopy micrographs at 90X. (A.) Normal (Control)
Condition (B.) Carrier Condition, and (C.) Affected Condition.
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Transmission Electron Microscopy
TEM allowed the visual examination of horse skin fibroblast cellular makeup in
normal (control), carrier, and affected conditions; this is important because cell shape is
maintained through structural stiffness by way of the cell’s internal components.
Figure 9 shows the internal components of the fibroblast of the three conditions
studied. TEM of fibroblasts at 14,000X magnification from the normal horse (Figure 9A)
shows cellular components including the nucleus, mitochondria, lysosomes, and
endoplasmic reticulum. Likewise, in Figure 9B, the same components are observed. TEM
micrograph of affected condition, shown in Figure 9C, demonstrates many of the same
and/or similar cellular components, but they appear abnormal and unhealthy, in
comparison to, the normal (control) and carrier conditions.
Preliminary veterinarian pathology consultation of TEM micrographs did not
present significant characterization of either three conditions. With this, future work
(discussed later) will be given to investigating the internal components of normal
(control), carrier, and affected conditions.
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B

C
Figure 9

Transmission Electron Microscopy micrographs at 14kX. (A.) Normal
(Control) Condition (B.) Carrier Condition, and (C.) Affected Condition.

Confocal Light Microscopy
Confocal Light Microscopy was obtained after DAPI and Rhodamine-Phalloidin
counter-stain was applied to the nucleus and actin filaments of the fibroblasts.
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Micrographs of normal (control) condition (Figure 10), carrier condition (Figure 11), and
affected condition (Figure 12) were taken using a 20X lens. Figures 10A, 11A, and 12A
show nuclei of each condition stained with DAPI (blue). Actin filaments of normal
(control), carrier, and affected conditions were stained with Rhodamine-Phalloidin (red)
illustrated in Figures 10B, 11B, and 12B, respectively. Combined images of counterstains of each condition are shown in Figures 10C, 11C, and 12C.
Visual analysis of confocal light microscopy included the following: 1.) Similar
sizes and shapes of nuclei appeared throughout each condition, and 2.) Actin filaments of
affected condition appear to be thin and narrow compared to cells of normal and carrier
conditions. This portion of the study led to more investigations of HC/HERDA including
quantifying nucleic components.
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Figure 10

Confocal Images of Normal Cells at 20X. (A.) Cell nuclei stained with
DAPI (B.) Actin filaments stained with Rhodamine-Phalloidin (C.)
Fibroblast counter-stained with DAPI and Rhodamine-Phalloidin.
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Figure 11

Confocal Images of Carrier Cells at 20X. (A.) Cell nuclei stained with
DAPI (B.) Actin filaments stained with Rhodamine-Phalloidin (C.)
Fibroblast counter-stained with DAPI and Rhodamine-Phalloidin.
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Figure 12

Confocal Images of Affected Cells at 10X. (A.) Cell nuclei stained with
DAPI (B.) Actin filaments stained with Rhodamine-Phalloidin (C.)
Fibroblast counter-stained with DAPI and Rhodamine-Phalloidin.

Confocal Light Microscopy – Image J Software
To quantify cell shape and size, confocal light micrographs were analyzed using
Image J Software (National Institute of Health, Baltimore, MD). Confocal Images
(Figures 13A, 14A, and 15A) were isolated to DAPI Channel, imported into the analyzer,
and converted into 8-bit binary file. In order to achieve accurate data of cells, noise and
distortion was eliminated by using THRESHOLD and REMOVE OUTLIERS
Commands and transferred into grayscale images, shown in Figures 13B, 14B, and 15B.
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Further procedures included adjusting the sharpness of individual cells in the image area
to obtain an average cell count and cell shape. This was completed in a black and white
image using a pencil tool demonstrated in Figures 13C, 14C, and 15C. Final steps also
included utilizing ANALYZE PARTICLES for quantifying the cells of each condition in
the given area; the analyzer generates a drawing of the total number of cells shown in
Figures 13D, 14D, and 15D. The parameters provided by typical analysis were COUNT,
TOTAL AREA, and AVERAGE SIZE.
Visual analysis showed the nucleus of the normal cells appeared to be slightly
more elongated than the nucleus of the other conditions which appeared to be more round
in shape; this led to measuring the average size and circularity of the cells from each
condition. Concomitantly, confocal micrographs and Image J Software (National Institute
of Health, Baltimore, MD) allowed the comparison of cell count, average cell size, and
circularity between each condition presented below in Table 4. Cell count of normal cells
was more than that of carrier and affected cells, but showed no significant difference. The
average cell size of carrier and affected cells was relatively the same (~2.5 µm), and
insignificantly larger than the normal conditions.
Table 4

Analysis of Cellular Components from HC Horses via Confocal Imaging &
Image J Software

Analysis of Cellular Components form HC via Confocal Imaging & Image J Software
Cell Count

Average Cell Size (µm)

Normal (Control)

120

2.163

Carrier

93

2.457

Affected

89

2.482
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Normal (Control) Condition

Figure 13

A

B

C

D

Confocal Micrographs and Image J Analysis of cells from Normal
Condition. (A.) Confocal micrograph of DAPI stained nuclei (B.) Noise
reduced image (514 x 514 pixels; 8-bit; 258k) of A. (C.) B&W image with
adjusted cell sharpness of A (514 x 514 pixels; 8-bit; 258k). (D.)
Quantified drawing of C (514 x 514 pixels; 8-bit; 258k).
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Carrier Condition

A

B

C
Figure 14

D

Confocal Micrographs and Image J Analysis of cells from Carrier
Condition. (A.) Confocal micrograph of DAPI stained nuclei (B.) Noise
reduced image (514 x 514 pixels; 8-bit; 258k) of A. (C.) B&W image with
adjusted cell sharpness of A (514 x 514 pixels; 8-bit; 258k). (D.)
Quantified drawing of C (514 x 514 pixels; 8-bit; 258k).
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Affected Condition

Figure 15

A

B

C

D

Confocal Micrographs and Image J Analysis of cells from Affected
Condition. (A.) Confocal micrograph of DAPI stained nuclei (B.) Noise
reduced image (514 x 514 pixels; 8-bit; 258k) of A. (C.) B&W image with
adjusted cell sharpness of A (514 x 514 pixels; 8-bit; 258k). (D.)
Quantified drawing of C (514 x 514 pixels; 8-bit; 258k).
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Cellular Proliferation
Assay results of cellular proliferation are presented in this section; fibroblasts
were studied at three predetermined times (4, 12, and 18 hours). The outcome of BrdU
incorporated cells of each condition at 4 hours was the following:
Table 5

Incorporated BrdU at 4 hours in Normal condition. Sample size (n = 6).
Cell Count of Incorporated BrdU at 4 Hours in Normal Condition

Table 6

Sample 1

176.3193

Sample 2

372.3003

Sample 3

240.0793

Sample 4

381.9053

Sample 5

359.7113

Sample 6

342.5893

Incorporated BrdU at 4 hours in Carrier condition. Sample size (n = 6).
Cell Count of Incorporated BrdU at 4 Hours in Carrier Condition
Sample 1

375.4693

Sample 2

280.3653

Sample 3

312.1513

Sample 4

354.3653

Sample 5

411.0143

Sample 6

412.2363
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Table 7

Incorporated BrdU at 4 hours in Affected condition. Sample size (n = 6)
Cell Count of Incorporated BrdU at 4 Hours in Affected Condition
Sample 1

409.2703

Sample 2

436.3163

Sample 3

450.8883

Sample 4

491.3423

Sample 5

465.5743

Sample 6

451.6893

The mean and standard deviation of incorporated BrdU of each condition was
determined to give:
Table 8

Calculations of incorporated BrdU at 4 hours. Mean and standard deviation
for each condition.
Incorporated BrdU at 4 Hours (n=6)
Normal

Carrier

Affected

Mean

312.15

357.60

450.85

St. Dev.

84.04

53.29

27.56

BrdU at 12 Hours
Results of BrdU incorporated cells of each condition at 12 hours were the
following:
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Table 9

Incorporated BrdU at 12 hours in Normal condition. Sample size (n = 6).
Cell Count of Incorporated BrdU at 12 Hours in Normal Condition

Table 10

Sample 1

353.2462

Sample 2

370.5932

Sample 3

236.2832

Sample 4

254.6752

Sample 5

343.2742

Sample 6

376.7072

Incorporated BrdU at 12 hours in Carrier condition. Sample size (n = 6).
Cell Count of Incorporated BrdU at 12 Hours in Carrier Condition
Sample 1

382.8412

Sample 2

295.6942

Sample 3

342.0822

Sample 4

216.0232

Sample 5

367.5752

Sample 6

350.4112
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Table 11

Incorporated BrdU at 12 hours in Affected condition. Sample size (n = 6).

Cell Count of Incorporated BrdU at 12 Hours in Affected Condition
Sample 1

479.2832

Sample 2

527.5522

Sample 3

423.2422

Sample 4

470.4472

Sample 5

452.5042

Sample 6

513.6412

The mean and standard deviation of incorporated BrdU of each condition was
determined to give:
Table 12

Calculations of incorporated BrdU at 12 hours. Mean and standard deviation
for each condition.
Incorporated BrdU at 12 Hours (n=6)
Normal

Carrier

Affected

Mean

322.46

325.77

477.78

St. Dev.

61.09

61.36

38.56

BrdU at 18 Hours
BrdU incorporated cells of each condition at 18 hours resulted in the following:
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Table 13

Incorporated BrdU at 18 hours in Normal condition. Sample size (n = 6).
Cell Count of Incorporated BrdU at 18 Hours in Normal Condition

Table 14

Sample 1

220.5003

Sample 2

327.8463

Sample 3

330.0923

Sample 4

379.0243

Sample 5

364.5053

Sample 6

329.8623

Incorporated BrdU at 18 hours in Carrier condition. Sample size (n = 6).
Cell Count of Incorporated BrdU at 18 Hours in Carrier Condition
Sample 1

205.2053

Sample 2

199.3223

Sample 3

243.6463

Sample 4

148.8313

Sample 5

322.7433

Sample 6

228.6613
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Table 15

Incorporated BrdU at 18 hours in Affected condition. Sample size (n = 6).

Cell Count of Incorporated BrdU at 18 Hours in Affected Condition
Sample 1

202.2103

Sample 2

194.5223

Sample 3

179.3873

Sample 4

306.5793

Sample 5

305.9623

Sample 6

219.8203

The mean and standard deviation of incorporated BrdU of each condition was
determined to give:
Table 16

Calculations of incorporated BrdU at 18 hours. Mean and standard deviation
for each condition.
Incorporated BrdU at 18 Hours (n=6)
Normal

Carrier

Affected

Mean

325.31

224.73

234.75

St. Dev.

55.60

57.91

56.91

Overall statistical results of cellular proliferation show interesting data of
incorporated BrdU between each condition. After 4 hours of BrdU incorporation, cells of
the affected condition, with a mean of 450.85 and standard deviation of 27.56,
incorporated at higher rate than both normal and carrier condition. Whereas, cells of the
carrier condition showed a mean of 357.60 and standard deviation of 53.29, and cells of
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normal (control) condition had a mean of 312.15 and standard deviation of 84.04. At the
12 hour testing interval, cells of the normal (control) condition and affected condition
continued to increase in BrdU incorporation with a mean of 322.46 and 477.78,
respectively. In contrast, cells of carrier condition decreased with a mean of 325.77 and a
standard deviation of 61.36. Finally, after 18 hours, cells of normal condition continued
to increase with a mean of 325.31 and a standard deviation of 55.60. Interestingly, both
carrier and affected conditions took on similar characteristics and decreased in DNA
incorporation with corresponding means of 224.73 and 234.75.
Apoptosis
Results obtained from Serum Starvation and Mechanical Stretching Induced
Apoptosis experiments are presented in this chapter. For comparison purposes, Figure 16
and 17 were used as Negative Control and Positive Control for both studies. Negative
control represents normal (healthy) cells stained with propidium iodide (PI). Positive
control indicates normal (healthy) cells stained with both, staurospourin to induce
apoptosis, and PI. It is important to note the Side Scatter (SSC) and Forward Scatter plots
demonstrate selected population used for analysis; the selected population is represented
by markers inside the circle area.
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Figure 16

Side and Forward Scatter-plot (top) and Histogram (bottom) of Negative
Control. Normal (healthy) condition cells stained with PI.
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Figure 17

Side and Forward Scatter-plot (top) and Histogram (bottom) of Positive
Control. Normal (healthy) condition cells stained with staurosporin and PI.

Serum Starvation
Results obtained from serum starvation of each condition are presented in this
section; Figure 18 illustrates cells of normal condition, Figure 19 represents cells of
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carrier condition, and Figure 20 shows cells of affected condition. For all conditions, the
peak range indicates cellular behaviors after 24–hours of serum starvation.

Figure 18

Side and Forward Scatter-plot (top) and Histogram (bottom) of Serum
Starved Normal cells.
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Figure 19

Side and Forward Scatter-plot (top) and Histogram (bottom) of Serum
Starved Carriers cells.
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Figure 20

Side and Forward Scatter-plot (top) and Histogram (bottom) of Serum
Starved Affected cells.

Mechanical Stretching
Results obtained from mechanical stretching of each condition are presented in
this section; Figure 21 illustrates cells of normal condition, Figure 22 represents cells of
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carrier condition, and Figure 23 shows cells of affected condition. For all conditions, the
peak range indicates cellular behavior after 20% mechanical stretch for 10 hours.

Figure 21

Side and Forward Scatter-plot (top) and Histogram (bottom) of Mechanical
stretched Normal cells.
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Figure 22

Side and Forward Scatter-plot (top) and Histogram (bottom) of Mechanical
stretched Carrier cells.
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Figure 23

Side and Forward Scatter-plot (top) and Histogram (bottom) of Mechanical
stretched Affected cells.
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CHAPTER V
DISCUSSION AND CONCLUSION
Findings in Hyperelastosis Cutis (HC) or Hereditary Equine Regional Dermal
Asthenia (HERDA) combined with knowledge of its human counterpart, Ehlers-Danlos
Syndrome (EDS) results in obscure understanding of disease basis or cause. For example,
EDS is a clinically and genetically heterogeneous group of hereditable connective tissue
disorders caused by abnormalities and defects in the collagen fiber structure resulting
from mutations in the collagen genes, and in genes that encode other proteins that affect
the nature of the extracellular matrix (Borges 2005; Byers 1989; Giunta 1999; Mao 2001;
Whitelaw 2003). In addition, HC is also a connective tissue disorder resulting in lesions
most often found on the dorsum, back, and withers which have been reported to develop
on average 1.5-2 years of age (Brounts 2001; Carmalt 2004; Schott 2005; Tryon 2007;
White 2004). Research points out force, pressure, stress of saddling combined with riders
weight leads to severe wounds in affected horses (Brounts 2001; Carmalt 2004; White
2004; Tryon 2007). Other characteristics include slow-healing wounds, and poor
adhesion in the dermis of the skin. These facts led to our attempt to analyze the
biochemical and micromechanical effects of the connective tissue disorder as a three-part
study which included electron microscopy analysis, cellular proliferation assay, and
apoptosis study. Specific aims upon completion were to (1) analyze and quantify cellular
proliferation of HC normal, carrier, and affected fibroblasts, and (2) characterize the
effects of induced apoptosis of HC normal, carrier, and affected fibroblasts (via serum
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starvation and mechanical stretching). Results from each portion of the study exemplified
novel information to give insight on the disease.
Interpretation of the Analysis Parameters
Speculations from previous EDS research prompted test and methodologies in this
study. Specifically, the recognition of frequent ultrastructural abnormalities of collagen
fibrils in EDS patients led to the concept that EDS is a disorder of fibrillar collagen
metabolism (Mao 2001) gave insight on HC leading to microstructural analysis. Electron
microscopy analysis was executed through Scanning Electron Microscopy, Transmission
Electron Microscopy, and Confocal Light Microscopy; each segment was vital to the
overall study suggesting pertinent visual and quantitative analysis. SEM micrographs
(Figures 7B and 7C) showed cells of carrier and affected condition take on similar initial
growth patterns and cells of normal condition begin growing in a uniform, structured
manner (Figure 7A). Through TEM micrographs, it appeared that cells of normal and
carrier condition (Figure 8A and 8B) were healthy illustrating distinctive cellular
components. In contrast, cells of affected condition, in Figure 8C, appeared to be
abnormal and unhealthy as hypothesized. This is probably due to an irregularity in
metabolism of the affected condition which is later discussed as a “specialized” method
of metabolizing.
Confocal light micrographs and Image J Analyzer Software allowed the analysis
and quantification of cell nuclei from normal, carrier, and affected condition. Results
from Table 4 showed affected cells to grow faster than normal and carrier cells, but they
were at least 7 times smaller than normal and carrier cells. Collectively, it is visually
proven this diseased condition (HC affected cells) have specialized functions to
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proliferate at a higher rate than the two other conditions, even with its unhealthy internal
appearance.
In many cases, the ability of the cell to perform its function depends on maturity
including shape, size, and internal components. Fibroblasts have high importance in the
overall health of skin; they are long and narrow cells in shape that are present in the
dermis (Tinker 1985; Wang 2006). Producing collagen and elastin fibers, which are the
major building blocks of the skin, fibroblast cells aids in its structural integrity. Elastin is
a structural protein found in the skin. Another important function of mature cells is
migration; for example, when cells from surrounding undamaged tissue migrate to
wounds, they aid in renewing tissue, which assists in the wound healing process. Also,
cellular development processes know as protrusion, adhesion, contraction and rear release
contributes to cell migration as the organism grows its various parts. With this, it was
essential to confirm these visual analyses with quantifications of fibroblast proliferation
between each condition giving insight on cellular development.
As defined, cell proliferation is a measurement of the number of cells dividing in
a sample. Bromodeoxyuridine (5-bromo2’-deoxy-uridine or BrdU) assay will allow the
quantification of DNA synthesis or cell proliferation in each condition of this study. From
assay results after 4 hours of BrdU incorporation (Table 6), the cells from affected
condition with mean and standard deviation of (450.85 ± 27.56) proliferated at a
significantly higher rate than normal condition (312.15 ± 84.04) and carrier condition
(357.60 ± 53.29). Table 8 demonstrated after 12 hours, affected cells (477.48 ± 38.56)
begin to function as normal cells (322.46 ± 61.09) by continued increase in proliferation;
where, carrier cells decreased in proliferation with mean and standard deviation of
(325.77 ± 61.36). This trend also continued after 18 hours of incorporated BrdU, carrier
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condition decreased to (224.73 ± 57.91); pointing out, the affected condition also
followed a similar path and began a proliferation decline with a mean and standard
deviation of (234.75 ± 56.91). However, cells of the normal condition remained
increasing in cellular proliferation. From these results, an overall understanding of
differences in cell growth between the three conditions was obtained. Cells of normal
(control) condition grow at a much slower rate, than that of the affected cell condition,
but these cells maintain a consistent healthy environment. Carrier cells perform closer to
those of affected condition by rapid increase in initial stages of proliferation, but tend to
become dormant over a short period of time (once cells have reached a specific level of
confluence), and slack in cell division. However, these results provided the following
questions during the study: (1) At this dormant period, are cells at a vulnerable state
causing poor metabolism production? (2) If so, is the membrane integrity of each
condition compromised during this developmental phase? This short series of questions
warranted the additional study of the effects of induced apoptosis on HC normal, carrier,
and affected cells.
Previous research illustrates biochemical measurements and microarray analysis
of gene expression show that mechanical loading leads to a synthetic cellular phenotype
characterized by increased matrix synthesis and decreased matrix degradation. Wang
points out physiological or pathological effects in the ECM are caused because of the
cells’ response to mechanical forces on the tissue. Focus on the ECM was very important
in this study because it is composed of proteins including collagen, elastin and
glycoprotein; in addition to, proteoglycans that provides strength and attachment sites for
cell surface receptors. The ECM also regulates cell proliferation, migration, and
differentiation (Wang 2006). Many studies have shown mechanical forces affect the gene
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induction, protein synthesis, cells growth, and cell death. The mechanical forces is
associated to the force, pressure, stress of saddling combined with rider’s weight that
leads to severe wounds in affected horses (Brounts 2001; Carmalt 2004; Tryon 2007;
White 2004). In the present study, cell death was induced, via serum starvation and
mechanical stretching, on HC normal, carrier, and affected conditions. Results from both
apoptosis experiments displayed significant information.
Specifically, serum starvation proved with a gated population some cells of
condition, normal (control), carrier, or affected, underwent apoptosis after 24 hours of
serum deprivation. Before being discussed, note cells contain different amounts of DNA
depending on the stage in the cell cycle. It can be determined what percentages of cells
are in the different parts of the cycle based on intensity of fluorescent of the nuclei.
Figure 18 demonstrates serum starved of normal (control) condition encountered an
insignificant amount of cells to undergo apoptosis because there was only a slight shift to
right. Serum starved of affected condition, shown in Figure 20, illustrates the same
results. However, cells of the carrier condition that were serum starved peaked closer to
101, and had a percentage of cells fluorescing in apoptotic range. In conclusion, affected
condition behaves as normal (control) condition; whereas, a higher percentage of cells of
carrier condition underwent apoptosis. This shift was closer to peak of Positive Control
(stained with both staurosporin and PI). Again, this shows cells of the affected condition,
with abnormalities in microstructure, have a specialized method of metabolizing even
without serum. In addition, results from mechanical stretched induced apoptosis showed
none of cells from normal (control) or affected conditions underwent apoptosis after 10
hours of 20% strain (stretching), but a significant percentage of cells of the carrier
condition underwent apoptosis under the same variables. Figure 21 and 23 show very
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similar peaks, at 101, of normal (control) and affected conditions. In contrast, the peak of
carrier condition after 10 hours of 20% strain, shown in Figure 22, peaks near 102
indicate a large number of cells are apoptotic. Because reports states severe lesions
develop at 1.5-2 years of age in combination with rider’s weight and saddling, our
predetermined methods (24 hours of serum starvation and 10 hours of 20% strain) of
inducing apoptosis are not sufficient to cause total cellular membrane compromising.
This is probably because at point of testing time (70 - 80% confluence), cells have
already formed the vast and firm networks within the ECM.
Summary
EDS and HC are, both, connective tissue disorders resulting in loose, sloughingskin, seromas and hematomas, and slow healing wounds (Carmalt 2004; Mao 2001;
Schott 2005; Tryon 2007; White 2004). A Biochemical and Micromechanical Study was
designed to seek out and report novel information on the vague disease Hyperelastosis
cutis.
Throughout the study, cells of normal (control) condition and cells of affected
condition take on many of the same behaviors in response to the biochemical and
micromechanical effects. But the carrier condition is clinically more closely related to
normal (control) condition after diagnosis.
Extracting principles from both apoptosis and cell proliferation results, because
the cells of carrier and affected condition take a turn in proliferation at/after 12 hours, it is
suggested to perform apoptosis studies early in cell development stages (lower
confluence of 20-30%). This may provide a better understanding exact time frame when
these cells are vulnerable and not metabolically producing at full potential. Other
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suggestions for future work include increasing mechanical load intensity applied to cells
of each condition symbolically representing the combined weight of rider and saddle.
EDS is caused by abnormalities and defects in the collagen fiber structure
resulting from mutations in collagen genes, mutations in genes which encode enzymes
that modify collagens, and mutations in genes that encode other proteins that affect the
nature of extracellular matrix (Byers 1989). With the information obtained from the three
conditions of HC/HERDA in this thesis work, it is relevant to confirm that the HC
disease is very similar to EDS in humans. A target of this study was to provide
information to assist in the development of treatment for HC affected horses; it is desired
that these findings could be correlated to find addition links in HC disease’s human
counterpart, Ehlers-Danlos Syndrome.
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APPENDIX A
PROTOCOLS
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Apoptosis/DNA Isolation Protocol
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Cell Staining and Counterstaining Protocol
Formaldehyde-Fixed Cells
1. Wash cells twice with pre-warmed phosphate-buffered saline, pH 7.4 (PBS)
2. Fix the sample in 3.7% formaldehyde (paraformaldehyde) solution in PBS for
10 minutes at room temperature.
Note: Methanol can disrupt actin during fixation process. Therefore, it is
best to avoid any methanol containing fixatives. The preferred fixative is
methanol-free formaldehyde.
3. Wash two or more times with PBS
4. Place each coverslip in a glass Petri dish and extract it with a solution of acetone
at ≤ -20ºC or 0.1% Triton X-100 in PBS for 3 to 5 minutes. (Permeabilize)
5. Wash two or more times with PBS
6. When staining with any of the fluorescent phallotoxin, dilute 5 µL methanolic
stock solution into 200 µL PBS for each coverslip to be stained. To reduce
nonspecific background staining with these conjugates, add 1% bovine serum
albumin (BSA) to the staining solution. It may also be useful to pre-incubate fixed
cells with PBS containing 1% BSA or with the Image-iT FX signal enhancer
(I36933) for 20-30 minutes prior to adding the phallotoxin staining solution.
**When staining more than one coverslip, adjust volumes accordingly. For
stronger signal, use 2 or 3 units per coverslip.
7. Place the staining solution on the coverslip for 20 minutes at room temperature
(Generally, any temperature between 4ºC and 37ºC is suitable). To avoid
evaporation, keep the coverslips inside a covered container during the incubation.
8. Wash two or more times with PBS.
9. For long-term storage, the cells should be air dried and then mounted in a
permanent mountant such as ProLong Gold reagent or Cytoseal. Specimens
prepared in this manner retain staining for at least six months when stored in the
dark at 2-6ºC.
Note: After fixing and permeabilization, stain specifically.
Counterstaining Adherent Cells for Fluorescent Microscopy
1. Sample Preparation-Use the fixation protocol appropriate for your sample.
DAPI staining is normally performed after all other staining. Note that fixation
and permeabilization of the sample are not necessary for counterstaining with
DAPI.
2. Counterstaining Protocol
a. Equilibrate the sample briefly with phosphate-buffered saline (PBS).
b. Dilute the DAPI stock solution to 300 nM in PBS. Add ~ 300 µL of this
dilute DAPI staining solution to the coverslip preparation, making certain
that the cells are completely covered.
c. Incubate for 1-5 minutes.
d. Rinse the sample several times in PBS. Drain excess buffer from the
coverslip and mount. We recommend using a mounting medium with an
antifade reagent such as our SlowFade Gold antifade reagent (S36936) or
ProLong Gold anitfade reagent (P36930).
e. View the sample using a fluorescent microscope with appropriate filters.
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Cell Freezing and Thawing Protocol
Freezing Cells:
Cells should be growing well or known to be in log phase
Count, collect and pellet cells in a 15mL test tube
Resuspend in freezing media so that the concentration is no more than
5x10^6 cells/mL of cold freezing media (see below for freezing media
recipe)
Transfer 1mL of cells to appropriately labeled cryovials and maintain on
ice for approximately 30minutes
Transfer vials to -80C freezer for 24hrs
Transfer to liquid nitrogen dewar or -140C freezer for long-term storage.
Freezing media
o 10% DMSO
o 90% FCS
o you'll need 1mL per 5x10^6 cells
Thawing Cells:
Remove vial from Liquid Nitrogen or -140C freezer and immediately
transfer to 37C water bath
While holding the tip of the vial, gently agitate the vial, being careful not
to allow water to penetrate the cap or seal
When completely thawed, transfer contents of vial to 15mL test tube
Slowly add 10mL warm complete media and spin at 1000g for 5min
Decant media and resuspend pellet in a volume of complete media
appropriate for flask or macrowell
Transfer cells to flask or 24 well plate and incubate at 37C and 5%CO2
Cells can be checked visually or counted, beginning at approximately 1hr,
for an estimate of viability.
Immediate cell counts can be misleading
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Fibroblast Cryo-Preservation Protocol (Adapted from Swiderski-Fall 2006)
Notes:
-Procedure must be aseptic in its entirety (containers, instruments, solutions, air, etc.)
-(D-)PBS=(Dulbecco’s) phosphate buffered saline; FBS=fetal bovine serum
1. Collect cells from flask:
-remove and discard all media
-wash cell surface (2x is optimal) with a few drops to 1–3mL PBS for ~1 minute
(1" well=few drops, T25=1mL, T75=2mL, T150=3mL)
-remove and discard wash
-add trypsin solution to cell layer and rotate container to coat entire surface
(1" well=2 drops, T25=0.5mL, T75=1mL, T150=1.5mL)
-remove typsin after 2 minutes in an incubator (without disturbing cells)
-manual rotation/agitation may be intermittent or continuous, but progress of cell
release should be evaluated visually +/- microscopically every 1–2 minutes
***Agitation at this stage may be vigorous, including firmly hitting container
against countertop (incubator environment speeds enzymatic reaction)
-when most cells have released, immediately add media (w/ FBS) to trypsin/cell
solution in order to inactivate trypsin (otherwise, cell damage continues)
(quantity media = ~5+ times the amount of trypsin used)
-pipette cell-solution in and out several times, rinsing chamber bottom (forcefully)
of remaining adherent cells and homogenizing the cell distribution.
-pipette cells into a 15mL conical tube w/ cap
2. Count cells using the usual cell-count protocol.
3. Centrifuge the cell solution at 1500rpm for 10 minutes (remember to balance the
sample[s]).
4. Decant the supernatant solution and re-suspend the cell pellet in the residual.
5. Add cold media to volume (w/o 10% DMSO portion) at ideal concentration of
2.5x106 cells/mL; add DMSO dropwise last.
6. Distribute to labeled vials and put into -80 for 24 hours; move to cryo after 24
hours and within a few days at most.
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Fibroblast - Cell Culture Protocol (Adapted from Swiderski-Fall 2006)

Notes:
-procedure must be aseptic in its entirety (instruments, solutions, air, etc.)
-new cells should receive “start-up” media until out of T25 size flask, “complete” media after
-all solutions should be brought to 37˚C in a water bath before contacting cells
-(D-)PBS=(Dulbecco’s) phosphate buffered saline; FNC=fibronectin; FBS=fetal bovine serum
1.

Remove flask/plate from incubator. (Flask caps should be tightened while out of incubator and
flask solution should be tilted away from cap while moving.)

2.

Examine cell growth with inverted microscope (10x*10x power is usually sufficient).

3.

Manipulate cells and/or growth media as necessary, typically:
a. For continued maximum growth in same container:
-remove and discard expended media entirely and replace with fresh
Tip: apparently stalled growth may be bolstered w/ 15% FBS media
*during initial harvesting stage, only remove macro-tissue (or much of the media)
after cell adherence is certain and prominent
or
b. For reduced/maintenance growth in same container:
-remove and discard ½ of media and replace with fresh
or
c. Move cells to a different container (larger or smaller):
-remove and discard all media
-wash cell surface (2x is optimal) with a few drops to 1–3mL PBS for ~1 minute
(1" well=few drops, 1.5" well=0.5mL, T25=1mL, T75=2mL, T150=3mL)
-remove and discard wash
-add trypsin solution to cell layer and rotate container to coat entire surface
(1" well=2 drops, 1.5" well=4 drops, T25=0.5mL, T75=1mL, T150=1.5mL)
-remove plate/flask after 2 minutes in an incubator (without disturbing cells)
-manual rotation/agitation may be intermittent or continuous, but progress of cell
release should be evaluated visually +/- microscopically every 1–2 minutes
*agitation at this stage may be vigorous, including firmly hitting container
against countertop (incubator environment speeds enzymatic reaction)
-when most cells have released, immediately add media (w/ FBS) to trypsin/cell
solution in order to inactivate trypsin (otherwise, cell damage continues)
(quantity media = ~5+ times the amount of trypsin used)
-pipette cell-solution in and out several times, rinsing chamber bottom (forcefully)
of remaining adherent cells and homogenizing the cell distribution
-obtain 10–20μl for cell count and complete
-if count is acceptable, transfer cells to new chamber
*pass #1 (and #0) should utilize a chamber treated with FNC
-qs growing media to standard protocol for chosen container size
(1" well=2mL, T25=5–6mL, T75=20mL, T150=40mL)
-label with origin name (“patient”), date, contents/count, your name, & pass #

4.

Return to incubator (if flask, always w/ cap vented) at 37ºC, 70% humidity (at least), and 5% CO2;
monitor at least every 48 hours.
Cell movement
sample → 1" wells
sample → 1.5" wells
1" wells → T25 flask
T25 flask → T75 flask
T75 flask → T150 flask

Time to confluence
6 days
8–10 days
2.5 days
6 days
8 days
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Expected confluent cell count
0.5–0.9 x 106/well
1.5–2.0 x 106/well
3.0–6.0 x 106/ flask
9.0–12.0 x 106/ flask
18.0–22.0 x 106/ flask

Fibroblast - Cell Culture Media Recipe (Adapted from Swiderski-Fall 2006)
Complete (Maintenance) Media
10% Fetal Bovine Serum (FBS)
1 mL Pen/Strep per 100 mLs Media (0.01mL/mL)
Ex: 500 mL bottle media = 50mL FBS + 5.5 mL Pen/Strep
Start Up Media
20% FBS
1 mL Pen/Strep per 100 mLs Media (0.01mL/mL)
Fungizone (FZ) 100 μL/ 500 mL (0.2μL/mL)
Epidermal Growth Factor (EGF) 500 μL/ 500 mL (1μL/mL)
Note: Most often won’t be using 500 mL worth of start-up, determine how much media
needed and aliquot out from complete media and add FZ and EGF as needed.
Serum Free Media
1 mL Pen/Strep per 100 mLs Media (0.01mL/mL)
Trypsin 1X
Add 1 mL Stock Trypsin to 15 mL conical tube
Add 9 mL PBS
Freeze/Store in -20 freezer
*All media and ingredients must be brought to 37 °C in water bath prior to adding
to cells*
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